134 related articles for article (PubMed ID: 26690333)
1. Dual drug loaded nanoliposomal chemotherapy: A promising strategy for treatment of head and neck squamous cell carcinoma.
Mohan A; Narayanan S; Balasubramanian G; Sethuraman S; Krishnan UM
Eur J Pharm Biopharm; 2016 Feb; 99():73-83. PubMed ID: 26690333
[TBL] [Abstract][Full Text] [Related]
2. Novel resveratrol and 5-fluorouracil coencapsulated in PEGylated nanoliposomes improve chemotherapeutic efficacy of combination against head and neck squamous cell carcinoma.
Mohan A; Narayanan S; Sethuraman S; Krishnan UM
Biomed Res Int; 2014; 2014():424239. PubMed ID: 25114900
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistance.
Bajelan E; Haeri A; Vali AM; Ostad SN; Dadashzadeh S
J Pharm Pharm Sci; 2012; 15(4):568-82. PubMed ID: 23106959
[TBL] [Abstract][Full Text] [Related]
4. Pegylated liposome-encapsulated doxorubicin and cisplatin in the treatment of head and neck xenograft tumours.
Harrington KJ; Rowlinson-Busza G; Uster PS; Stewart JS
Cancer Chemother Pharmacol; 2000; 46(1):10-8. PubMed ID: 10912572
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies.
Zhang YF; Wang JC; Bian DY; Zhang X; Zhang Q
Eur J Pharm Biopharm; 2010 Mar; 74(3):467-73. PubMed ID: 20064608
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model.
Damiani V; Falvo E; Fracasso G; Federici L; Pitea M; De Laurenzi V; Sala G; Ceci P
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28718812
[TBL] [Abstract][Full Text] [Related]
8. Dual-effect liposomes encapsulated with doxorubicin and chlorin e6 augment the therapeutic effect of tumor treatment.
Peng PC; Hong RL; Tsai YJ; Li PT; Tsai T; Chen CT
Lasers Surg Med; 2015 Jan; 47(1):77-87. PubMed ID: 25559348
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
[TBL] [Abstract][Full Text] [Related]
10. Vascular targeting of doxorubicin using cationic liposomes.
Wu J; Lee A; Lu Y; Lee RJ
Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
[TBL] [Abstract][Full Text] [Related]
12. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
Shuhendler AJ; Cheung RY; Manias J; Connor A; Rauth AM; Wu XY
Breast Cancer Res Treat; 2010 Jan; 119(2):255-69. PubMed ID: 19221875
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
Wong HL; Bendayan R; Rauth AM; Wu XY
J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
[TBL] [Abstract][Full Text] [Related]
14. Enhancing delivery and cytotoxicity of resveratrol through a dual nanoencapsulation approach.
Soo E; Thakur S; Qu Z; Jambhrunkar S; Parekh HS; Popat A
J Colloid Interface Sci; 2016 Jan; 462():368-74. PubMed ID: 26479200
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin and chloroquine coencapsulated liposomes: preparation and improved cytotoxicity on human breast cancer cells.
Qiu L; Yao M; Gao M; Zhao Q
J Liposome Res; 2012 Sep; 22(3):245-53. PubMed ID: 22607110
[TBL] [Abstract][Full Text] [Related]
16. Comparison of injectable doxorubicin & its nanodrug complex chemotherapy for the treatment of 4-nitroquinoline-1-oxide induced oral squamous cell carcinoma in rats.
Khiavi MM; Abdal K; Abbasi MM; Hamishehkar H; Aghbali AA; Salehi R; Sina M; Abdollahi B; Fotohi S
Indian J Med Res; 2017 Jan; 145(1):112-117. PubMed ID: 28574023
[TBL] [Abstract][Full Text] [Related]
17. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB
Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112
[TBL] [Abstract][Full Text] [Related]
18. Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods.
Agarwal A; Mackey MA; El-Sayed MA; Bellamkonda RV
ACS Nano; 2011 Jun; 5(6):4919-26. PubMed ID: 21591812
[TBL] [Abstract][Full Text] [Related]
19. Polymersome-mediated delivery of combination anticancer therapy to head and neck cancer cells: 2D and 3D in vitro evaluation.
Colley HE; Hearnden V; Avila-Olias M; Cecchin D; Canton I; Madsen J; MacNeil S; Warren N; Hu K; McKeating JA; Armes SP; Murdoch C; Thornhill MH; Battaglia G
Mol Pharm; 2014 Apr; 11(4):1176-88. PubMed ID: 24533501
[TBL] [Abstract][Full Text] [Related]
20. Cellular uptake and anticancer activity of salvianolic acid B phospholipid complex loaded nanoparticles in head and neck cancer and precancer cells.
Li H; Shi L; Wei J; Zhang C; Zhou Z; Wu L; Liu W
Colloids Surf B Biointerfaces; 2016 Nov; 147():65-72. PubMed ID: 27490455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]